Why Is Hyrimoz So Hard to Find? [Explained for 2026]

You have a prescription for Hyrimoz. You call your pharmacy. They don't have it. You call another. Same answer. You search online and can't find a clear explanation. Sound familiar?

The frustrating truth is that Hyrimoz (adalimumab-adaz) is not on any official drug shortage list. The FDA and the American Society of Health-System Pharmacists (ASHP) both show no national shortage for this medication as of 2026. And yet, patients across the country are struggling to get it filled on time. Here's why — and what you can do about it.

What Is Hyrimoz, and Who Uses It?

Hyrimoz is an FDA-approved biosimilar to Humira (adalimumab), manufactured by Sandoz Inc. It launched in the U.S. on July 1, 2023, and is approved for nine conditions: rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and uveitis.

Millions of Americans rely on adalimumab products to control serious inflammatory diseases. Hyrimoz offers the same clinical effectiveness as Humira at a lower list price — and the FDA has designated it as interchangeable with Humira, meaning pharmacists can substitute it without calling your doctor in most states.

Is Hyrimoz Actually in a Shortage in 2026?

No — not officially. As of early 2026, adalimumab-adaz is not listed as a drug shortage by the FDA or ASHP. Sandoz continues to manufacture and distribute Hyrimoz across the United States. However, Sandoz did discontinue certain low-concentration Hyrimoz formulations (specific NDC numbers) in January 2026, noting that equivalent Sandoz formats remain available. This means if your pharmacy was stocking a specific presentation, they may have needed to switch to a different packaging format.

That said, "not in shortage" doesn't mean "easy to find." There are several structural reasons why you may be running into walls even when the medication technically exists somewhere.

Why Can't I Find Hyrimoz at My Pharmacy?

Here are the five most common reasons patients struggle to fill Hyrimoz in 2026:

1. Hyrimoz Is a Specialty Drug — and Most Retail Pharmacies Don't Stock It

Hyrimoz requires refrigeration and costs thousands of dollars per dose. Most retail pharmacies — your local CVS, Walgreens, or Walmart — do not routinely stock specialty biologics. Even large chain pharmacies typically dispense adalimumab products through their dedicated specialty pharmacy division, not from the retail counter.

Specialty pharmacies that do carry Hyrimoz include CVS Specialty, Accredo, OptumRx Specialty, and AllianceRx Walgreens Prime. If you've been filling at a retail location, you may need to transfer your prescription to one of these specialty pharmacies.

2. Insurance Formularies Are Constantly Shifting

One of the biggest drivers of Hyrimoz access issues in 2026 is insurance formulary changes. Starting in 2024, major pharmacy benefit managers (PBMs) began aggressively removing brand-name Humira from preferred formularies in favor of lower-cost biosimilars. But the biosimilar they prefer isn't always Hyrimoz — it depends on which manufacturer your PBM has a contract with.

CVS Caremark prefers Hyrimoz and its Cordavis private-label version. Express Scripts (Quallent) prefers Cyltezo. Optum Rx (Nuvaila) has its own preferred products. If your insurance uses a PBM that prefers a different biosimilar, your Hyrimoz prescription may be denied — even though Hyrimoz is clinically interchangeable.

3. Prior Authorization Causes Delays

Biologics like Hyrimoz almost universally require prior authorization (PA) from your insurance company. This means your doctor must submit documentation proving the medication is medically necessary before your insurance will cover it. This process can take days to weeks, and if your PA expires or requires renewal, you may face a gap in supply.

Many insurance plans also require step therapy — meaning you must try and fail one or more conventional medications (like methotrexate) before they will approve a biologic. This can delay access for new patients by weeks or months.

4. The Cordavis Complication: Brand vs. Private Label

CVS Health created a subsidiary called Cordavis in 2023 to co-commercialize a private-label version of Hyrimoz. This unbranded version of Hyrimoz — adalimumab-adaz without the Hyrimoz name — is the same medicine but listed at an even lower price. Some pharmacies and plans now dispense the Cordavis version instead of branded Hyrimoz.

If your prescription specifically says "Hyrimoz" but your pharmacy only stocks the Cordavis private-label version, this can create confusion — even though the drug is medically identical. Your pharmacist should be able to help clarify, and in most cases, the unbranded version can be substituted.

5. Retail Pharmacy Stocking Is Inconsistent

Even specialty pharmacies may not carry every formulation of Hyrimoz. The drug comes in multiple strengths (10 mg, 20 mg, 40 mg, 80 mg) and two concentration formulations (low-concentration and high-concentration citrate-free). Your pharmacy may stock the high-concentration pen but not the low-concentration syringe, for example. This mismatch between what's prescribed and what's stocked is a common reason for delays.

What Can You Do If You Can't Find Hyrimoz?

Here are concrete steps you can take right now:

Contact your doctor's office and ask them to call pharmacies on your behalf or engage the Sandoz One Source patient support team at 1-833-497-4669.

Ask your doctor whether an interchangeable biosimilar (such as Hadlima or Cyltezo) could be temporarily substituted if your insurance prefers one of those.

Try calling specialty pharmacies directly — CVS Specialty, Accredo, OptumRx Specialty, and AllianceRx Walgreens Prime are the primary distributors for Hyrimoz.

Use medfinder — medfinder calls pharmacies near you to find out which ones have Hyrimoz in stock, so you don't have to make dozens of calls yourself.

Don't Skip Doses — Plan Ahead

Missing doses of Hyrimoz can cause your inflammatory condition to flare. Adalimumab works by maintaining consistent drug levels in your body — and gaps in treatment can allow the underlying disease to return, sometimes making it harder to achieve remission again once you restart. Experts recommend contacting your pharmacy at least 2 weeks before you run out of medication.

For the latest on Hyrimoz availability, read our Hyrimoz shortage update for 2026.

The Bottom Line

Hyrimoz isn't in a national shortage, but the combination of specialty pharmacy requirements, insurance formulary politics, and prior authorization hurdles can make it genuinely difficult to fill. The good news: with the right tools and a proactive approach, most patients can get their medication on time. See our guide on how to find Hyrimoz in stock near you for step-by-step help.